Acute Respiratory Distress Syndrome Clinical Trial
— PARAVENTOfficial title:
Ventilation's Parameters Applied in Emergency Medicine. Observational Study
NCT number | NCT03351920 |
Other study ID # | PARAVENT |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | November 7, 2017 |
Est. completion date | August 8, 2019 |
Verified date | February 2020 |
Source | Poitiers University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
To prospectively assess the mechanical ventilation management when its provided by Emergency
Physicians in French Hospital, and to assess complications and outcome of these patients.
The study could be measure the proportion of patients developing an Acute Respiratory Failure
Distress after a take care of by French Emergency Departments.
Status | Completed |
Enrollment | 229 |
Est. completion date | August 8, 2019 |
Est. primary completion date | July 22, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Age equal or over 18 years old - Needing a invasive or noninvasive mechanical ventilation - Mechanical ventilation initiated in Prehospital or IntraHospital Emergency Department by an Emergency Physician Exclusion Criteria: - Age under 18 years old |
Country | Name | City | State |
---|---|---|---|
France | Pierre-Arnaud Fort | Agen | |
France | CHU de Bordeaux | Bordeaux | |
France | Pierre-Marie Noël | Brest | |
France | Paul Fievet | La Rochelle | |
France | Thomas Lenormand | Lorient | |
France | CH de Niort | Niort | |
France | Marjanovic Nicolas | Poitiers |
Lead Sponsor | Collaborator |
---|---|
Poitiers University Hospital |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of patients benefiting of a early low-volume ventilation initiated Emergency Department or Prehospital Care. | Early Low volume ventilation will be defined according to a VtE < 8mL/lg | Day 1 | |
Secondary | Proportion of patients benefiting of an early protective ventilation in Emergency Departments | Day 1 | ||
Secondary | Proportion of patients with acute respiratory distress syndrome according to the Berlin Definition during the first eight days of following. | ARDS will be defined according to the Berlin definition. | from Day 1 to Day 8 and Day 28 | |
Secondary | Proportion of survival from day 1 to Day 8, and to day 28 | from Day 1 to Day 8 and Day 28 | ||
Secondary | Indication to mechanical ventilation in Prehospital care and Emergency Departments | Day 1 | ||
Secondary | Mechanical Ventilation Duration in Emergency Departments | Day 1 | ||
Secondary | Mechanical ventilation settings in Emergency Departments | Recorded settings will be Ventilation mode, Tidal volume or Pressure Support Positive End Expiratory Pressure, Ventilation Rate, I : E ratio or Inspiratory Flow or Inspiratory Time. | Day 1 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Recruiting |
NCT05535543 -
Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
|
||
Completed |
NCT04695392 -
Restore Resilience in Critically Ill Children
|
N/A | |
Terminated |
NCT04972318 -
Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia
|
N/A | |
Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
Completed |
NCT04078984 -
Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
|
||
Completed |
NCT04451291 -
Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure
|
N/A | |
Not yet recruiting |
NCT06254313 -
The Role of Cxcr4Hi neutrOPhils in InflueNza
|
||
Not yet recruiting |
NCT04798716 -
The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
|
Phase 1/Phase 2 | |
Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT02881385 -
Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation
|
N/A | |
Terminated |
NCT02867228 -
Noninvasive Estimation of Work of Breathing
|
N/A | |
Completed |
NCT02545621 -
A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
|
||
Withdrawn |
NCT02253667 -
Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients
|
N/A | |
Completed |
NCT02232841 -
Electrical Impedance Imaging of Patients on Mechanical Ventilation
|
N/A | |
Completed |
NCT02889770 -
Dead Space Monitoring With Volumetric Capnography in ARDS Patients
|
N/A | |
Completed |
NCT01504893 -
Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia
|
N/A | |
Withdrawn |
NCT01927237 -
Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide
|
N/A | |
Completed |
NCT02814994 -
Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients
|
N/A | |
Completed |
NCT01680783 -
Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure
|
N/A |